Purdue Pharma (United States)
In research, Purdue Pharma (United States) stands highest in Medicine (#5,111 of 17,978 worldwide) and Health Sciences (#6,692 of 20,462 worldwide), over all time.
- World rank, all time
- #17,976 of 42,892
- Rank in United States
- #3,907 of 8,685
- Research works
- 294 ▼ 85% vs 2013–17
- Citations
- 6.7k 22.8 per fractional work
- Top-10% rate
- 23.6% record average 16.5%
- Open access
- 31% world 28%
What is Purdue Pharma (United States) known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| MedicineField | #5,111 of 17,978 | 17.2% | 158 | |
| Health SciencesDomain | #6,692 of 20,462 | 18.0% | 169 |
Each strip is that field’s whole ranked pool, with the notch where Purdue Pharma (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Veterinary, 31.2×. Every wedge is a field page.
Who are the top researchers at Purdue Pharma (United States)?
Ranked on the composite score, J. David Haddox and Meredith Y. Smith lead among researchers whose main affiliation is Purdue Pharma (United States).
- 1 J. David Haddox United States · #212,108 worldwide 189 citations · 18 works
- 2 Meredith Y. Smith United States · #1,272,014 worldwide 20 citations · 18 works
Which keywords describe research at Purdue Pharma (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Substance Use Disorders, Mortality Risk, Chronic Pain Management, Opioid Prescribing, Pain Management, Pain Assessment Tools, Postoperative Pain and Quality of Life.
- Opioid
- Neuropeptides
- Weight Loss
- Adverse Events
- Calcium Signaling
- Polypharmacy
- Crystal Structure
- Ion Channels
- Pharmacology
- Method Validation
- Depression
- Glial Activation
- Neuropathic Pain
- Neuroinflammation
- Clinical Trials
- Opioid Analgesics
- Postoperative Pain
- Quality of Life
- Opioid Prescribing
- Mortality Risk
- Substance Use Disorders
- Chronic Pain Management
- Pain Management
- Pain Assessment Tools
- Cancer Pain
- Chronic Pain
- Nociception
- Neuronal Plasticity
- Central Sensitization
- Pain Modulation
- Cell Signaling
- Drug Discovery
- Stress
- Anxiety
- Inappropriate Medication Use
- Synaptic Plasticity
- Calcitonin Gene-Related Peptide
- Immune Modulation
- Anti-Obesity Drugs
- Pharmacotherapy
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Substance Use Disorders40▲ 203×2 topics
- Mortality Risk36▲ 60×3 topics
- Chronic Pain Management36▲ 517×1 topic
- Opioid Prescribing36▲ 517×1 topic
- Pain Management33▲ 50×6 topics
- Quality of Life30▲ 7.6×14 topics
- Pain Assessment Tools30▲ 193×2 topics
- Postoperative Pain30▲ 102×3 topics
- Cancer Pain26▲ 333×1 topic
- Opioid Analgesics26▲ 333×1 topic
- Chronic Pain21▲ 31×4 topics
- Clinical Trials16▲ 8.8×9 topics
- Nociception15▲ 82×2 topics
- Neuroinflammation14▲ 18×4 topics
- Neuronal Plasticity14▲ 57×2 topics
- Neuropathic Pain14▲ 58×3 topics
- Central Sensitization13▲ 59×2 topics
- Glial Activation13▲ 57×1 topic
- Pain Modulation13▲ 89×1 topic
- Depression11▲ 5.2×12 topics
- Cell Signaling11▲ 11×6 topics
- Method Validation10▲ 46×3 topics
- Drug Discovery10▲ 8.7×7 topics
- Pharmacology9▲ 9.0×7 topics
- Stress8▲ 7.0×5 topics
- Ion Channels8▲ 13×3 topics
- Anxiety8▲ 7.1×9 topics
- Crystal Structure7▲ 9.5×3 topics
- Inappropriate Medication Use7▲ 59×1 topic
- Polypharmacy7▲ 59×1 topic
- Synaptic Plasticity7▲ 7.5×4 topics
- Calcium Signaling7▲ 17×4 topics
- Calcitonin Gene-Related Peptide7▲ 26×2 topics
- Adverse Events6▲ 33×2 topics
- Immune Modulation6▲ 15×2 topics
- Weight Loss6▲ 13×2 topics
- Anti-Obesity Drugs6▲ 90×1 topic
- Neuropeptides6▲ 19×2 topics
- Pharmacotherapy6▲ 85×1 topic
- Opioid6▲ 34×1 topic
Which research topics does Purdue Pharma (United States) publish most on?
By volume in 2022–2025: Opioid Use Disorder Treatment, Forensic Toxicology and Drug Analysis, Poisoning and overdose treatments and Neuropeptides and Animal Physiology.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Opioid Use Disorder Treatment Public Health, Environmental and Occupational Health 1 works
- 2 Forensic Toxicology and Drug Analysis Toxicology 0 works
- 3 Poisoning and overdose treatments Emergency Medicine 0 works
- 4 Neuropeptides and Animal Physiology Cellular and Molecular Neuroscience 0 works
- 5 Attention Deficit Hyperactivity Disorder Psychiatry and Mental health 0 works
- 6 Receptor Mechanisms and Signaling Molecular Biology 0 works
- 7 Animal testing and alternatives Small Animals 0 works
- 8 Neuroscience of respiration and sleep Endocrine and Autonomic Systems 0 works
- 9 Pain Mechanisms and Treatments Physiology 0 works
- 10 Advancements in Transdermal Drug Delivery Pharmaceutical Science 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Purdue Pharma (United States)'s research output changed?
Output in 2018–2022 was 85% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Stamford
- Stamford Hospital
- Gaertner (United States)
- Short and Associates (United States)
- Ferguson Library
- New England Institute for Neurology and Headache
- Sema4 (United States)
- Cara Therapeutics (United States)
- Harman (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.